MacroGenics, Inc. (MGNX) financial statements (2022 and earlier)

Company profile

Business Address 9704 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments123181 220305277
Cash and cash equivalents123181 22021284
Short-term investments    93193
Receivables1023 30143
Inventory, net of allowances, customer advances and progress billings4     
Inventory4     
Prepaid expense2117 633
Other undisclosed current assets12091 1301
Total current assets:280313 269322284
Noncurrent Assets
Property, plant and equipment3842 575018
Long-term investments and receivables     8
Long-term investments     8
Other noncurrent assets1824 621
Total noncurrent assets:5666 635227
TOTAL ASSETS:335379 332374311
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4942 374120
Accounts payable168 424
Accrued liabilities3434 333916
Deferred revenue214 
Deferred rent credit   1
Restructuring reserve    02
Deferred revenue and credits86
Other liabilities   00 
Other undisclosed current liabilities54 22  
Total current liabilities:7551 605027
Noncurrent Liabilities
Long-term debt and lease obligation2125    
Operating lease, liability2125 
Liabilities, other than long-term debt07 102515
Deferred revenue and credits2515
Deferred revenue 7 
Deferred rent credit   10
Restructuring reserve     0
Other liabilities0     
Other undisclosed noncurrent liabilities   19  
Total noncurrent liabilities:2132 292515
Total liabilities:9683 897543
Stockholders' equity
Stockholders' equity attributable to parent240296 243299269
Common stock11 000
Additional paid in capital1,2131,067 733611561
Accumulated other comprehensive loss(0)(0) (0)(0)(0)
Accumulated deficit(974)(772) (490)(312)(293)
Total stockholders' equity:240296 243299269
TOTAL LIABILITIES AND EQUITY:335379 332374311

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues77105 6015892
Revenue, net15892
Cost of revenue
(Cost of Goods and Services Sold)
(3)     
Gross profit:75105 6015892
Operating expenses(278)(236) (231)(180)(152)
Operating loss:(203)(131) (171)(22)(60)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
11 (0)32
Net loss available to common stockholders, diluted:(202)(130) (171)(20)(59)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(202)(130) (171)(20)(59)
Comprehensive loss:(202)(130) (171)(20)(59)
Other undisclosed comprehensive loss, net of tax, attributable to parent(0)(0)    
Comprehensive loss, net of tax, attributable to parent:(202)(130) (171)(20)(59)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: